Ocuvex Therapeutics
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Bridge Plz N Ste 2, Fort Lee, New Jers...Phone Number
(877) 622-9326Website
www.ocuvextherapeutics.comRevenue
<$5 MillionIndustry
About Ocuvex Therapeutics
Ocuvex Therapeutics Org Chart
Is Ocuvex Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Ocuvex Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Ocuvex Therapeutics is spiking on competitors!
Product Launch: Get notified when Ocuvex Therapeutics launches new products
Funding: Get notified immidiatlly once Ocuvex Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Ocuvex Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Ocuvex Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ocuvex Therapeutics
Earning: See what the market has to say on Ocuvex Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Ocuvex Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Ocuvex Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ocuvex Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ocuvex Therapeutics.
Ocuvex Therapeutics News & Media
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
CINCINNATI, July 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates, today announced that they have entered into a definitive merger agreement (the “Merger Agreement”).Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options, today announced that they have signed a Non-Binding Letter of Intent contemplating a potential business combinatio
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ocuvex Therapeutics
Based in Fort Lee, New Jersey, Ocuvex Therapeutics, Inc is an ophthalmic pharmaceutical company focused on developing and commercializing novel therapies for glaucoma and other disorders.... Read More